0001179110-14-012973.txt : 20140815 0001179110-14-012973.hdr.sgml : 20140815 20140815190022 ACCESSION NUMBER: 0001179110-14-012973 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140813 FILED AS OF DATE: 20140815 DATE AS OF CHANGE: 20140815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE JUNNING CENTRAL INDEX KEY: 0001596187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 141047689 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgar.xml FORM 4 - X0306 4 2014-08-13 0 0001080014 THERAVANCE INC THRX 0001596187 LEE JUNNING THERAVANCE, INC. 951 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Sr. VP, Technical Operations Common Stock 2014-08-13 4 M 0 13882 9.81 A 258324 D Common Stock 2014-08-13 4 M 0 12516 14.53 A 270840 D Common Stock 2014-08-13 4 M 0 24338 12.66 A 295178 D Common Stock 2014-08-13 4 M 0 23705 12.66 A 318883 D Common Stock 2014-08-13 4 S 0 53424 22.50 D 265459 D Stock Option (Right to Buy) 9.81 2014-08-13 4 M 0 13882 0 D 2014-09-03 Common Stock 13882 0 D Stock Option (Right to Buy) 14.53 2014-08-13 4 M 0 12516 0 D 2015-02-09 Common Stock 12516 0 D Stock Option (Right to Buy) 12.66 2014-08-13 4 M 0 24338 0 D 2014-10-03 Common Stock 24338 0 D Stock Option (Right to Buy) 12.66 2014-08-13 4 M 0 23705 0 D 2014-10-03 Common Stock 23705 0 D This transaction was executed in multiple trades at prices from $22.49 to $22.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or the security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected. Exercisable immediately. Junning Lee 2014-08-15